Oncology Institute, Inc.·4

Apr 13, 9:03 AM ET

Chernett Jorey 4

4 · Oncology Institute, Inc. · Filed Apr 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Oncology Institute (TOI) 10% Owner Chernett Jorey Buys 20,000 Shares

What Happened

Chernett Jorey, reported as a greater-than-10% owner of Oncology Institute, Inc. (TOI), purchased 20,000 shares on April 9, 2026 at $3.10 per share, a total cost of $62,000. The Form 4 lists the transaction code "P" (purchase) and indicates an open‑market or private purchase. This was a buy (acquisition), which is generally considered more informative for investors than routine insider selling.

Key Details

  • Transaction date: April 9, 2026; reported on Form 4 filed April 13, 2026 (within the 2-business-day filing window).
  • Price and quantity: 20,000 shares at $3.10 each; total value $62,000.
  • Shares owned after transaction: Not specified in the filing.
  • Transaction code: P (purchase); described as open-market or private purchase.
  • Footnotes/conditions: No 10b5-1 plan, tax withholding, or other special footnotes disclosed in the filing.

Context

As a 10% owner, Jorey is a significant beneficial owner rather than (necessarily) an executive; purchases by large insiders can reflect a desire to increase exposure but do not alone prove future company performance. This filing is factual disclosure of the transaction; retail investors should combine it with other company and market information before drawing conclusions.

Insider Transaction Report

Form 4
Period: 2026-04-09
Transactions
  • Purchase

    Common Stock

    2026-04-09$3.10/sh+20,000$62,00010,499,358 total
Signature
/s/ Jorey Chernett|2026-04-13

Documents

1 file
  • 4
    form414528003_04132026.xmlPrimary

    OWNERSHIP DOCUMENT